Logo image of CAF.PA

CR DE CREDIT AGRICOLE IDF (CAF.PA) Stock Earnings & Estimates

EPA:CAF - FR0000045528 - Common Stock

103.9 EUR
+3.4 (+3.38%)
Last: 8/29/2025, 7:00:00 PM

Full estimates are only available for subscribed users, you can see which data is available below.

Subscribed users also see more surprise data, now it is restricted to 4 quarters.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2022 2023 2024
Revenue
YoY % growth
CAF.PA revenue by date.CAF.PA revenue by date.
1.358B
8.93%
1.178B
-13.25%
1.126B
-4.40%
EBITDA
YoY % growth
CAF.PA ebitda by date.CAF.PA ebitda by date.
N/AN/AN/A
EBIT
YoY % growth
CAF.PA ebit by date.CAF.PA ebit by date.
N/AN/AN/A
Operating Margin
CAF.PA operating margin by date.CAF.PA operating margin by date.
N/AN/AN/A
EPS
YoY % growth
CAF.PA eps by date.CAF.PA eps by date.
N/AN/AN/A

All data in EUR

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
EPS
Q2Q % growth
Revenue
Q2Q % growth
EBITDA
Q2Q % growth
EBIT
Q2Q % growth

All data in EUR

Recent Earnings VS Estimates Surprises (EUR)
PeriodReportedEstimateDifferenceSurprise
Recent Revenue VS Estimates Surprises (EUR)
PeriodReportedEstimateDifferenceSurprise
Q2 2025
Q2Q % growth
595.283M
0.49%
%
Q4 2024
Q2Q % growth
533.493M
-3.35%
%
Q2 2024
Q2Q % growth
592.365M
-5.69%
%
Q4 2023
Q2Q % growth
551.995M
-12.86%
%
Q2 2023
Q2Q % growth
628.093M
-13.79%
%
Q4 2022
Q2Q % growth
633.466M
1.43%
%
Q2 2022
Q2Q % growth
728.6M
16.68%
%
Q4 2021
Q2Q % growth
624.561M
8.11%
%
Q2 2021
Q2Q % growth
624.465M
15.21%
%
Q4 2020
Q2Q % growth
577.72M
2.52%
%
Q2 2020
Q2Q % growth
542.04M
-8.76%
%
CAF.PA Yearly Revenue VS EstimatesCAF.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPSN/A N/A N/A N/A
RevenueN/A N/A N/A N/A